Search by Drug Name or NDC

    NDC 68180-0779-13 ZOLPIDEM TARTRATE 6.25 mg/1 Details

    ZOLPIDEM TARTRATE 6.25 mg/1

    ZOLPIDEM TARTRATE is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is ZOLPIDEM TARTRATE.

    Product Information

    NDC 68180-0779
    Product ID 68180-779_0b0d439e-9812-4697-a98b-023eb50fb972
    Associated GPIs 60204080100410
    GCN Sequence Number 059696
    GCN Sequence Number Description zolpidem tartrate TAB MPHASE 6.25 MG ORAL
    HIC3 H2E
    HIC3 Description SEDATIVE-HYPNOTICS,NON-BARBITURATE
    GCN 25456
    HICL Sequence Number 007842
    HICL Sequence Number Description ZOLPIDEM TARTRATE
    Brand/Generic Generic
    Proprietary Name ZOLPIDEM TARTRATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name Zolpidem Tartrate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 6.25
    Active Ingredient Units mg/1
    Substance Name ZOLPIDEM TARTRATE
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA078970
    Listing Certified Through 2025-12-31

    Package

    NDC 68180-0779-13 (68180077913)

    NDC Package Code 68180-779-13
    Billing NDC 68180077913
    Package 5 BLISTER PACK in 1 CARTON (68180-779-13) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (68180-779-11)
    Marketing Start Date 2014-04-11
    NDC Exclude Flag N
    Pricing Information N/A